To observe the efficacy of oral fluconazole versus 5% amrolfine nail lacquer in the patients of Onychomycosis.
Not Applicable
- Conditions
- Health Condition 1: L609- Nail disorder, unspecified
- Registration Number
- CTRI/2020/12/029904
- Lead Sponsor
- Dr Ruchir M Bhatt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with any age.
Patients suffering from at least one Toenail onychomycosis with or without matrix involvement.
Exclusion Criteria
Pregnant or lactating women
Suffering from other nail conditions (e.g., psoriasis) which might interfere in the interpretation of results
Those on treatment with a topical or systemic antifungal during 4 weeks preceding screening.
with cardiac, hepatic, or renal comorbidities
those having history of hypersensitivity to any of the drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine more efficient treatment between fluconazole and amrolfine.Timepoint: At Baseline, at 12 weeks, at 24 weeks
- Secondary Outcome Measures
Name Time Method to observe most common mycological species in onychomycosisTimepoint: 24 weeks